Labuan, Arlyn .

HRN: 07-62-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2025
CEFUROXIME 1.5GM (VIAL)
06/07/2025
06/13/2025
IV
1.5g
Q8
D&c
Waiting Final Action 
06/08/2025
CEFUROXIME 1.5GM (VIAL)
06/08/2025
06/09/2025
IV
1.5g
Q8
D&c
Waiting Final Action 
06/08/2025
CEFUROXIME 500MG (TAB)
06/10/2025
06/16/2025
PO
500mg
Q8
D&c
Waiting Final Action 
06/08/2025
CEFUROXIME 500MG (TAB)
06/10/2025
06/16/2025
PO
500mg
BID
D&c
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: